Development and validation of a stability-indicating RP-UPLC method for determination of rosuvastatin and related substances in pharmaceutical dosage form

Scientia Pharmaceutica

Volumn 80, Issue 2, 2012, Pages 393-406

  Trivedi, Harshal Kanubhai ^a   Patel, Mukesh C ^b  

^a Cadila Pharmaceutical Ltd   (India)

^b PS Science and HDPatel Arts College   (India)

Author keywords

Forced degradation; Hyperlipidemia; Impurities; Liquid chromatography; Method validation; Rosuvastatin calcium; Rosuvastatin tablets; UPLC

Indexed keywords

METHANOL; ROSUVASTATIN; SOLVENT; TRIFLUOROACETIC ACID;

ACIDITY; ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DETERMINATION; DRUG IMPURITY; ELUTION; MASS SPECTROMETRY; MONITORING; OXIDATIVE STRESS; PRACTICE GUIDELINE; REVERSED PHASE LIQUID CHROMATOGRAPHY; TABLET; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

EID: 84865115491     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1201-09     Document Type: Article

References (21)

1. Lennernäs H, Fager G. Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors: Similarities and Differences. Clin Pharmacokinet. 1997; 32: 403. http://dx.doi.org/10.2165/00003088-199732050-00005
2. Akademiai K. Determination of rosuvastatin calcium in its bulk drug and pharmaceutical preparations by high-performance thin layer chromatography. J Planar Chromatogr. 2005; 18: 194-198. http://dx.doi.org/10.1556/JPC.18.2005.3.4
3. Uyar B, Celebier M, Altinoz S. Spectrophotometric determination of rosuvastatin calcium in tablets. Pharmazie. 2007; 62: 411-413. http://dx.doi.org/10.1691/ph.2007.6.6188
4. Alka G, Mishra P, Shah K. Simple UV spectrometric determination of rosuvastatin calcium in pure from and in pharmaceutical formulation. E-J Chem. 2009; 6: 89-92.
5. Prajapati PB, Bodiwala KB, Marolia BP, Rathod IS, Shah SA. Development and validation of extractive spectrophotometric method for determination of rosuvastatin calcium in pharmaceutical dosage forms. J Pharm Res. 2010; 3: 2036-2038.
6. Amr MB, Nadia MM, Abd EB, Abd EA, Nesrine TL. Stability indicating spectrophotometric method for determination of rosuvastatin in the presence of its acid degradation products by derivative spectrophotometric techniques. J Adv Pharm Res. 2011; 2: 44-55.
7. Hasumati AR, Rajput SJ, Dave JB, Patel CN. Development and validation of two chromatographic stability-indicating methods for determination of rosuvastatin in pure from and pharmaceutical preparation. Int J Chem Tech Res. 2009; 1: 677-689.
8. Indian Pharmacopoeia, Ghaziabad. The Indian Pharmacopoeia commission. 2007; 3: 1676-1678.
9. Chirag BP, Channabasavaraj KP, Chudasama JD, Mani TT. Development and validation of RP-HPLC method for determination of rosuvastatin calcium in bulk and pharmaceutical dosage form. Int J Pharma Sci Rew Res. 2010; 5: 82-86.
10. Sandhya D, Meriga KK, Teja GS, Kumar YM, Krishna JY, Ramesh D. A new validated RP-HPLC method for determination of rosuvastatin calcium in bulk and pharmaceutical dosage form. Der Pharmacia Lettre. 2011; 3: 350-356.
11. Jamil S, Ansari TA, Singh RM, Mathur SC, Nivoria CS, Pandey M K, Singh GN. Determination of rosuvastatin calcium in pharmaceutical dosage form y RP-HPLC method. Indian Drugs. 2005; 42: 98-101.
12. Suslu I, Celebier M, Altinoz S. Determination of rosuvastatin in pharmaceutical formulations by capillary zone electrophoresis. Chromatographia. 2007; 66: 65-72. http://dx.doi.org/10.1365/s10337-007-0221-y
13. Hull CK, Penman AD, Smith CK, Martin PD. Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection. J Chromatogr B. 2002; 772: 219-228. http://dx.doi.org/10.1016/S1570-0232(02)00088-0
14. Gao J, Zhong D, Duan X, Chen X. Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of rosuvastatin in human plasma: Application to a pharmacokinetic study. J Chromatogr B. 2007; 856: 35-40. http://dx.doi.org/10.1016/j.jchromb.2007.05.012
15. Xu DH, Ruan ZR, Zhou Q, Yuan H, Jiang B. Quantitative determination of rosuvastatin in human plasma by liquid chromatography with electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 2006; 20: 2369-2375. http://dx.doi.org/10.1002/rcm.2542
16. Kumar TR, Shitut NR, Kumar PK, Vinu MC, Kumar CC, Mullangi R, Srinivas NR. Determination of rosuvastatin in rat plasma by HPLC: Validation and Its application to pharmacokinetic studies. Biomed Chromatogr. 2006; 20: 881-887. http://dx.doi.org/10.1002/bmc.611
17. Dujuan Z, Jing Z, Xiaoyan L, Chunmin W, Rui Z, Haojing S, Han Y, Guiyan Y, Benjie W, Ruichen G. Validated LC-MS/MS method for the determination of rosuvastatin in human plasma: Application to a bioequivalence study in Chinese volunteers. Pharmacol Pharm. 2011; 2: 341-346. http://dx.doi.org/10.4236/pp.2011.24044
18. Shah Y, Iqbql Z, Ahmad L, Khan A, Khan MI, Nazir S, Nasir F. Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC/UV detection: Method development, validation and optimization of various experimental parameters. J Chromatogr B. 2011; 879: 557-563. http://dx.doi.org/10.1016/j.jchromb.2011.01.004
19. Mehta TN, Patel AK, Kulkarni GM, Subbaiah G. Determination of rosuvastatin in the presence of its degradation products by a stability indicating LC method. J AOAC Int. 2005, 88(4): 1142-1147. http://www.ncbi.nlm.nih.gov/pubmed/16152933
20. Gosula VRR, Bobba VR, Syed WH, Haum DG, Poonam K. Development and validation of a stability-indicating UPLC method for rosuvastatin and its related impurities in pharmaceutical dosage forms. Quim Nova. 2011; 34: 250-255. http://dx.doi.org/10.1590/S0100-40422011000200015
21. International conference on Harmonization (ICH). Validation of Analytical Procedure, Text and Methodology Q2(R1), IFPMA. Geneva, Switzerland, 2005.